Xiang Hong Lin

Xiang Hong Lin is currently the Chief Executive Officer at Suzhou Private Capital Investment Holdings Co. Ltd., Chairman at Suzhou Equity Investment Fund Management Co., Ltd., Director at Shenzhen SF Taisen Holdings Group, Inc., Non-Executive Director at CStone Pharmaceuticals Co. Ltd., and Director at Xi’An Jiaotong University Education Foundation.
Previously, he held positions such as Chairman & President at Suzhou Oriza Holdings Co. Ltd., Chairman & President at China Singapore Suzhou Industrial Park Ventures Co., Ltd., Chairman & President at Zhongxin Suzhou Industrial Park Venture Capital Co. Ltd., Non-Executive Director at Guangzhou Hangxin Aviation Technology Co., Ltd., Non-Executive Director at Lepu Biopharma Co., Ltd., and President at Suzhou Oriza Holdings Co. Ltd.
He also served as Deputy General Manager-Finance at China-Singapore Suzhou Industrial Park Development Co. Ltd.
and Deputy Manager-Finance & GM-Investment Department at Zhongxin Suzhou Industrial Park Development Co. Ltd.
Dr. Lin obtained a doctorate degree from Xi'an Jiaotong University in 2009, an undergraduate degree from Xi'an Jiaotong University in 1992, and a graduate degree from Soochow University in 1999.
Dr. Lin's current job(s) include Chief Executive Officer at Suzhou Private Capital Investment Holdings Co. Ltd., Chairman at Suzhou Equity Investment Fund Management Co., Ltd., Director at Shenzhen SF Taisen Holdings Group, Inc., Non-Executive Director at CStone Pharmaceuticals Co. Ltd., and Director at Xi’An Jiaotong University Education Foundation.